Enzolytics’ IPF Immune™ Provides a Comprehensive Natural Solution for Supporting Normal Immune Function

Enzolytics, Inc. is expanding its retail distribution network in the coming months for IPF Immune™, a dietary supplement for people who want to take a proactive approach to support their body’s natural immune system.

“IPF Immune™ is an incredible, natural, proprietary formula backed by science,” said Charles S. Cotropia, CEO of Enzolytics, Inc., a Texas-based biotech company. “Our patented technology is a unique formulation that supports normal immune function.”

Enzolytics, which is committed to developing effective and affordable therapeutics for treating a variety of conditions, is launching IPF Immune™ in the United States just as a record number of consumers are taking dietary supplements.

Mr. Cotropia said IPF Immune™ is produced in cGMP-certified manufacturing facilities with state-of-the-art production equipment to ensure the best healthy ingredients.

“Our research team took every precaution to develop the highest-quality immune support supplement,” he added. “When you buy IPF Immune™, you can be confident that you are getting a patented formulation designed to support your body’s natural immune function.”

Harry H. Zhabilov, Enzolytics’ Chief Scientific Officer, said IPF Immune™ is also gluten-and-GMO-free.

“Our immune system is vital to keeping us healthy,” Mr. Zhabilov said. “When our bodies come in contact with a virus, our immune system activates to fight against them. IPF Immune™ is a patented formula that is designed to help keep your immune system in tip-top condition, ready to quickly and efficiently keep you healthy and feeling good.”

IPF Immune™ is currently available on OneLavi.com, a boutique, health, and wellness website.

“We expect IPF Immune™ to be on Walmart.com in the coming weeks,” Mr. Cotropia said. “We also have a marketing campaign planned to promote IPF Immune™ to consumers through strategic press releases, outreach to media, and national TV tagging campaigns.“

For more information, email pr@nutrapr.com or visit enzolytics.com.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

Company Contact:

Enzolytics, Inc.
1101 Raintree Circle
Allen, Texas 75013

And

Research Center
Enzolytics, Inc.
Texas A&M University
Institute for Preclinical Studies
College Station, TX 77843-44

SOURCE: Enzolytics, Inc.

About Enzolytics, Inc.

Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases.